Preparation method of glycosyl and polypeptide modified 1, 2, 3-triazole compound
A technology for the modification of triazole compounds and polypeptides, which is applied in the field of combining organic synthesis and chemical biology, can solve the problems of harsh reaction conditions and narrow substrate range, and achieve the effect of simple operation and high potential application value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] The preparation of the compound shown in embodiment 1, formula Ⅰ-1
[0045]
[0046] Under air conditions, add trifluoromethyl-substituted acetonylidene-protected fructose (Formula 1) (0.2mmol), DABCO (0.4mmol), NaN 3 (0.8mmol), tetrahydropyrrole (Formula 3) (0.6mmol) and tetrahydrofuran (1.0mL). It was heated freely to 50°C and reacted for 12 hours. After the reaction was completed, 20 mL of ethyl acetate and 3.0 mL of 0.5 M dilute hydrochloric acid were added for extraction and separation, and the organic phase was washed with 3.0 mL of saturated brine, then dried, rotary evaporated, and subjected to column chromatography. After weighing, 46 mg of the compound represented by formula I-1 was isolated with a yield of 54%.
[0047] figure 1 Formula I-1 (((3aR,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolane) prepared for this example [4,5-b:4',5'-d]pyran-3a-yl)methyl 5-(pyrrolidin-1-yl)-1H-1,2,3-triazole-4-carboxylic acid The proton nuclear magne...
Embodiment 2
[0049] The preparation of the compound shown in embodiment 2, formula Ⅰ-2
[0050]
[0051]
[0052] Under air conditions, add trifluoromethyl-substituted acetonide-protected glucose (Formula 1) (0.2mmol), DABCO (0.4mmol), TMSN to the reaction tube in sequence 3 (0.8mmol), tetrahydropyrrole (Formula 3) (0.6mmol) and tetrahydrofuran (1.0mL). It was heated freely to 50°C and reacted for 12 hours. After the reaction was completed, 20 mL of ethyl acetate and 3.0 mL of 0.5 M dilute hydrochloric acid were added for extraction and separation, and the organic phase was washed with 3.0 mL of saturated brine, dried, rotary evaporated, and subjected to column chromatography. After weighing, 52 mg of the compound represented by formula I-2 was isolated, with a yield of 61%.
[0053] figure 2 (3aR,5R)-5-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyltetrahydrofuran prepared for the examples of the present invention 1H NMR Spectrum of [2,3-d][1,3]dioxo-6-yl 5-(pyrrolidin-1-yl)-1H...
Embodiment 3
[0055] The preparation of the compound shown in embodiment 3, formula Ⅰ-3
[0056]
[0057] Under air conditions, add trifluoromethyl-substituted acetonide-protected glucose (Formula 1) (0.2mmol), DABCO (0.4mmol), NaN 3 (0.8 mmol), proline methyl ester (Formula 3) (0.6 mmol) and tetrahydrofuran (1.0 mL). It was heated freely to 80°C and reacted for 12 hours. After the reaction was completed, 20 mL of ethyl acetate and 3.0 mL of 0.5 M dilute hydrochloric acid were added for extraction and separation, and the organic phase was washed with 3.0 mL of saturated brine, dried, rotary evaporated, and subjected to column chromatography. After weighing, 58 mg of the compound represented by formula I-3 was isolated, with a yield of 60%.
[0058] image 3 (3aR,5R)-5-((R)-2,2-dimethyl-1,3dioxolan-4-yl)-2,2-dimethyltetrahydrofuranyl 5 -((S)-2-(methoxycarbonyl)pyrrolidin-1-yl)-1H-1,2,3-triazole-4-carboxylate proton nuclear magnetic resonance spectrum, characterized as follows:
[005...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


